Literature DB >> 35095375

NF-KB A KEY TRANSCRIPTION FACTOR IN DISEASE PROGRESSION OF PATIENTS WITH COVID-19.

T G Shrihari1.   

Abstract

Covid19 is a current pandemic caused by SARS COVID2 virus. It is a RNA virus consists of outer spike glycoproteins. These PAMP's such as surface glycoproteins were recognized by PRR (pattern recognition receptors) belongs to TLR's especially TLR7 and TLR8 on immune cells activate NF-KB a key transcription factor involved in development of immunity. Dysregulated NF-KB a key transcription factor activates inflammatory mediators involved in disease progression in COVID patients. Targeting NF-KB, a key transcription factor and suppressing it, helps in suppressing the progression of disease for better prognosis. This article highlights about the NF-KB, a key transcription factor activity in progression of diseases in COVID19 patients, which is helpful for future therapeutic target and prognostic marker. © Association of Resident Doctors, UCH, Ibadan.

Entities:  

Keywords:  Glycoprotein's.; PAMP's (Pathogen associated molecular patterns); PRR (Pattern recognition receptors); TLR's (Toll like receptors)

Year:  2021        PMID: 35095375      PMCID: PMC8791396     

Source DB:  PubMed          Journal:  Ann Ib Postgrad Med


INTRODUCTION

The emergence and global spread of SARS-COV-2 causes COVID-19 is a major threat to the world. Because, of which WHO declared it as a pandemic on march 2020. SARS-COV-2 virus originated in the city of wuhan of china, many viral pneumonia cases were reported. Corona virus is a largest single stranded RNA virus consists of nucleocapsid includes genomic RNA and phosphorylated nucleocapsid (N) protein located inside phospholipid bilayer and consists of different spike proteins such as spike glycoprotein trimmer (S) present in all coronaviruses, HE (Haemagglutinin esterase) present in some coronaviruses, the M (Membrane) protein and E (Envelop) protein are present along with S protein in the virus. SARS-COV-2 virus enters the cell by binding to ACE2 (Angiotensin converting enzyme 2) receptor and the clinical presentations ranging from asymptomatic, fever, cough, dyspnea, pneumonia, respiratory failure , and death. SARS-COV-2 is related to SARS (SARS-COV-1) and MERS-COVs, caused zoonotic epidemic. SARSCOV-2 is not threat as SARS-COV-1 and MERS-COV. Spike protein of SARS-COV-2 trigger immune reaction leading to activation of NF-KB a key transcription factor involved in activation of antiviral cytokine such as IFN-γ. Dysregulated NF-KB transcription factor results in release of various inflammatory mediators such as cytokines, growth factors, and enzymes involved in tissue damage, viral pneumonia, respiratory failure and death. Current pandemic COVID-19 is caused by SARSCOV- 2 virus. This virus consists of S1 and S2 glycoprotein's has an affinity to bind with ACE receptors situated on respiratory tract[1,2]. Pathogen associated molecular pattern's recognized by pattern recognition receptors belongs to toll-like receptors (TLRs) present on immune cells especially TRL7 and TLR8 recognizes the surface glycoprotein's of SARSCOV- 2 virus. Abberated TLR's activate NF-KB, a desregulated NF-KB a key transcription factor involved in production of inflammatory mediators [1,3,4,10,11].

Mechanism of actions of NF-KB transcription factor

NF-KB a key transcription factor ubiquitous in cytoplasm of each cell in an inactive state by IkB (inhibitory kappa beta transcription factor), when it is activated degradation of inhibitory kappa beta transcription factor (IKB) by IKK kinases results in shifting of deregulated NF-KB from cytoplasm to nucleus binds with DNA leads to transcription of various inflammatory mediators such as proinflammatory cytokines (IL-1,TNF-α,IL-6), growth factors (EGF,FGF,VEGF), proteolytic enzymes UPA (Urokinase plasminogen activator), COX-2, MMP's (Matrix metallo proteinases), Free radicals (ROS,RNS), from inflammatory cells such as macrophages ,neutrophils, mast cells involved in chronic inflammation, immune modulation, lung alveoli tissue damage leads to cough, fever, breathlessness later results in severe acute respiratory distress syndrome[5-11] (Figure 1).
Figure 1:

Shows the NF-KB a key transcription factor activated by PAMP’s recognized by TLR involved in transcription of inflammatory mediators leads to disease progression in patients with COVID.

CONCLUSION AND FUTURE PERSPECTIVE

NF-KB a key transcription factor activated by PAMP's recognized by TLR7 and TLR8 involved in transcription of inflammatory mediators such as cytokines, growth factors, proteolytic enzymes involved in disease progression in patients with COVID19 Understanding of NF-KB a key transcription factor activity, activating factors, control of inflammatory mediators, which is helpful for future therapeutic target and prognostic marker.
  7 in total

Review 1.  Points of control in inflammation.

Authors:  Carl Nathan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

4.  Potential Co-Relation Between Chronic Periodontitis And Cancer - An Emerging Concept.

Authors:  T G Shrihari; V Vasudevan; V Manjunath; D Devaraju
Journal:  Gulf J Oncolog       Date:  2016-01

Review 5.  NF-kappaB: Two Sides of the Same Coin.

Authors:  Bruno R B Pires; Rafael C M C Silva; Gerson M Ferreira; Eliana Abdelhay
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

Review 6.  COVID-19: Immunology and treatment options.

Authors:  Susanna Felsenstein; Jenny A Herbert; Paul S McNamara; Christian M Hedrich
Journal:  Clin Immunol       Date:  2020-04-27       Impact factor: 3.969

Review 7.  Immunology of COVID-19: Current State of the Science.

Authors:  Nicolas Vabret; Graham J Britton; Conor Gruber; Samarth Hegde; Joel Kim; Maria Kuksin; Rachel Levantovsky; Louise Malle; Alvaro Moreira; Matthew D Park; Luisanna Pia; Emma Risson; Miriam Saffern; Bérengère Salomé; Myvizhi Esai Selvan; Matthew P Spindler; Jessica Tan; Verena van der Heide; Jill K Gregory; Konstantina Alexandropoulos; Nina Bhardwaj; Brian D Brown; Benjamin Greenbaum; Zeynep H Gümüş; Dirk Homann; Amir Horowitz; Alice O Kamphorst; Maria A Curotto de Lafaille; Saurabh Mehandru; Miriam Merad; Robert M Samstein
Journal:  Immunity       Date:  2020-05-06       Impact factor: 31.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.